Setting 
My Cart

Ordered before 17:30, shipped today - Support: (012) 800 456 789

Track Your Order

Toggle Nav
mobile icon
Close
  • Menu
  • Setting
  • Home
  • Search results for: 'research area apoptosis bcl 2 family'

Search results for: 'research area apoptosis bcl 2 family'

Items 11-20 of 133

Page
per page
  1. Golvatinib (E7050)
    B1439 Golvatinib (E7050)
    Target: VEGFR
    Summary: C-Met/VEGFR-2 inhibitor
  2. Regorafenib
    A8236 Regorafenib
     4 Citation
    Target: Raf|VEGFR|PDGFR|c-Kit|RET
    Summary: Inhibitor of VEGFR/PDGFR/FGFR/mutant kit/RET/Raf-1
      ≥25.04 mg/mL
  3. Regorafenib hydrochloride
    A3750 Regorafenib hydrochloride
    Target: Raf|VEGFR|PDGFR|c-Kit|c-RET
    Summary: Tyrosine kinase inhibitor
      ≥25.95 mg/mL
  4. TG101209
    A4145 TG101209
    Summary: JAK2/3 inhibitor
      ≥25.5 mg/mL
  5. Afatinib (BIBW2992)
    A8247 Afatinib (BIBW2992)
     1 Citation
    Target: EGFR
    Summary: Irreversible EGFR/HER2 inhibitor
      ≥24.3 mg/mL
  6. PD173955
    A8812 PD173955
    Target: Bcr-Abl|Src
    Summary: Dual Src/Abl kinase inhibitor, ATP-competitive,
      ≥22.15 mg/mL
  7. (Z)-FeCP-oxindole
    B5491 (Z)-FeCP-oxindole
    Summary: VEGFR-2 inhibitor
      insoluble in DMSO
  8. Amuvatinib (MP-470, HPK 56)
    A4237 Amuvatinib (MP-470, HPK 56)
    Summary: Tyrosine kinase inhibitor
      ≥22.4 mg/mL
  9. AEE788 (NVP-AEE788)
    A5455 AEE788 (NVP-AEE788)
    Summary: EGFR/HER-2/VEGFR inhibitor
      ≥22.05 mg/mL
  10. AC480 (BMS-599626)
    A2822 AC480 (BMS-599626)
    Target: EGFR
    Summary: HER1/2 inhibitor,selective and efficacious
      ≥28.35 mg/mL

Items 11-20 of 133

Page
per page
Shop By
Now Shopping by
  1. Category Tyrosine Kinase Remove This Item
Clear All
Shopping Options
Category
  1. Bcr-Abl 7item
  2. Ack1 1 item
  3. Axl 1 item
  4. ALK 4item
  5. Broad Spectrum Protein Kinase Inhibitor 3item
  6. c-FMS 1 item
  7. c-Kit 3item
  8. c-MET 8item
  9. c-RET 7item
  10. CSF-1R 1 item
  11. EGFR 28item
  12. FAK 4item
  13. FGFR 7item
  14. FLT3 6item
  15. HER2 6item
  16. IGF1R 3item
  17. Insulin Receptor 3item
  18. IRAK 1 item
  19. Lck 1 item
  20. LRRK2 4item
  21. PDGFR 10item
  22. PTKs/RTKs 1 item
  23. Pyk2 2item
  24. ROR 2item
  25. Spleen Tyrosine Kinase (Syk) 1 item
  26. Src 10item
  27. Tie-2 2item
  28. Trk 2item
  29. VEGFR 32item
Specificity
  1. Selective 52item
Reversibility
  1. Reversible 7item
  2. Irreversible 4item
Target
  1. Cyclin-Dependent Kinases 1 item
  2. Raf 5item
  3. Aurora Kinases 1 item
  4. CSF-1R 1 item
  5. FLT3 4item
  6. Eph Receptors 1 item
  7. VEGFR 27item
  8. PDGFR 8item
  9. c-Kit 6item
  10. RET 2item
  11. Bcr-Abl 3item
  12. FGFR 7item
  13. MET 4item
  14. Src 5item
  15. Trk Receptors 2item
  16. EGFR 12item
  17. FAK 3item
  18. BMP and Other Activin Receptors 1 item
  19. JAK 1 item
  20. Syk 1 item
  21. ErbB 2item
  22. c-MET 2item
  23. PKC 1 item
  24. Ca2 /calmodulin-dependent protein kinases (CaMKs) 1 item
  25. HER2 1 item
  26. Pyk2 3item
  27. LRRK2 4item
  28. Insulin and Insulin-like Receptors 2item
  29. ALK 1 item
  30. PKG 1 item
  31. PKA 1 item
  32. Myosin light chain kinases (MLCKs) 1 item
  33. Tie-2 3item
  34. c-Fyn 1 item
  35. ZAP-70 1 item
  36. Flk-1 1 item
  37. c-RET 1 item
  38. KDR 1 item
  39. Fyn kinase 1 item
  40. c-Fms tyrosine kinase 1 item
  41. Lyn kinase 1 item
  42. ErbB-2 1 item
  43. DCLK2 1 item
  44. Flk1 1 item
Reported Experiments
  1. Animal Experiments 65item
  2. Cell Experiments 46item
Related Disease
  1. Acute Myeloid Leukemia 2item
  2. Adrenocortical Carcinoma 1 item
  3. Advanced Renal Cell Carcinoma 1 item
  4. Autoimmune Diseases 1 item
  5. Bladder Cancer 3item
  6. Bladder Carcinoma 1 item
  7. Breast Cancer 14item
  8. Cancer 51item
  9. Cholangiocarcinoma 1 item
  10. Chronic Lymphocytic Leukemia 1 item
  11. Clear Cell Renal Cell Carcinoma 1 item
  12. Colon Cancer 3item
  13. Colon Carcinoma 1 item
  14. Colorectal Cancer 9item
  15. Glioblastoma 3item
  16. Glioma 2item
  17. Hepatocellular Carcinoma 2item
  18. Liver Cancer 2item
  19. Lung Cancer 5item
  20. Lung Carcinoma 1 item
  21. Lymphoma 1 item
  22. Melanoma 2item
  23. Multiple Myeloma 3item
  24. Non-small Cell Lung Cancer 3item
  25. Ovarian Cancer 4item
  26. Pancreatic Cancer 7item
  27. Prostate Cancer 5item
  28. Renal Cancer 2item
  29. Renal Cell Carcinoma 3item
  30. Thyroid Cancer 3item